Search - tctmd.com

Displaying 1 - 20 of 25

Sort: Relevancy | Date

News Industry News

Corvia Medical Announces Randomization of First Patient in the RESPONDER-HF Confirmatory Trial

December 06, 2022

Presentation TCT 2022

TCT 343: Evaluation of an Implant Free Interatrial Shunt to Improve Heart Failure: EASE HF

Presenter: Saibal Kar

September 18, 2022

Presentation TCT 2022

TCT 342: Early Multi-center Clinical Outcomes of a No-Implant Interatrial Shunt for Heart Failure with Preserved and Reduced Ejection Fraction: Latest Results From the Early Feasibility ALLEVIATE-HF Programs

Presenter: Roxana Mehran

September 18, 2022

Presentation TCT 2022

Left Atrial to Coronary Sinus Shunt Therapy In Heart Failure: Early Insights

Presenter: Benjamin Hibbert

September 17, 2022

Presentation TCT 2022

Pulmonary to Venous Shunt for Group 2 PH-HFpEF (NXT™ Rivet)

Presenter: Rob Taft

September 17, 2022

News Conference News TCT 2022

HF Devices Have a Role to Play, Even With Today’s GDMT Bonanza

Todd Neale

September 16, 2022

Presentation TCT 2022

The Interventional HF Innovation Landscape: What Is Working and What Is Not!

Presenter: Navin Kapur

September 16, 2022

Presentation TCT 2022

Moving Beyond Pharmacotherapy: The Transformative Role of Devices in HF Treatment

Presenter: William Abraham

September 16, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2022

Todd Neale

August 01, 2022

News Features

A Hole in the Heart for HFpEF? Setbacks, Progress for Interatrial Shunts

Shelley Wood

July 07, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2022

Shelley Wood

February 28, 2022

News Conference News THT 2022

Early Positive Signals From RELIEVE-HF Shift Discussion to Atrial Shunt Size

Shelley Wood

February 02, 2022

Presentation THT 2022

Interatrial Shunting in Chronic Heart Failure: Results From the RELIEVE-HF Roll-In Cohort

Presenter: JoAnn Lindenfeld

February 02, 2022

Presentation THT 2022

Alleviant Medical Pivotal Study Overview and Next Steps

Presenter: James Udelson

February 02, 2022

Presentation THT 2022

Alleviant Medical Technology, Procedure and Clinical Data

Presenter: Colin Barker

February 02, 2022

Presentation THT 2022

Clinical Data and Landscape of Interatrial Shunting

Presenter: Peter Fail

February 02, 2022

Presentation THT 2022

Overview of HFpEF Disease State and Physiological Rationale for Atrial Shunting

Presenter: JoAnn Lindenfeld

February 02, 2022

News Industry News

Landmark REDUCE LAP-HF II Trial Demonstrates Clinical Benefit of Corvia Atrial Shunt in Large Segment of Heart Failure Patients

February 02, 2022

News Conference News THT 2022

REDUCE LAP-HF II: Atrial Shunt Device Comes Up Short in HFpEF

Shelley Wood

February 01, 2022

Presentation THT 2022

Putting it into Perspective: Atrial Shunting in the Context of Current Therapies for HFpEF

Presenter: Scott Solomon

February 01, 2022

Advertisement

Corvia Medical Announces Randomization of First Patient in the RESPONDER-HF Confirmatory Trial

TCT 343: Evaluation of an Implant Free Interatrial Shunt to Improve Heart Failure: EASE HF

TCT 342: Early Multi-center Clinical Outcomes of a No-Implant Interatrial Shunt for Heart Failure with Preserved and Reduced Ejection Fraction: Latest Results From the Early Feasibility ALLEVIATE-HF Programs

Left Atrial to Coronary Sinus Shunt Therapy In Heart Failure: Early Insights

Pulmonary to Venous Shunt for Group 2 PH-HFpEF (NXT™ Rivet)

HF Devices Have a Role to Play, Even With Today’s GDMT Bonanza

The Interventional HF Innovation Landscape: What Is Working and What Is Not!

Moving Beyond Pharmacotherapy: The Transformative Role of Devices in HF Treatment

TCTMD’s Top 10 Most Popular Stories for July 2022

A Hole in the Heart for HFpEF? Setbacks, Progress for Interatrial Shunts

TCTMD’s Top 10 Most Popular Stories for February 2022

Early Positive Signals From RELIEVE-HF Shift Discussion to Atrial Shunt Size

Interatrial Shunting in Chronic Heart Failure: Results From the RELIEVE-HF Roll-In Cohort

Alleviant Medical Pivotal Study Overview and Next Steps

Alleviant Medical Technology, Procedure and Clinical Data

Clinical Data and Landscape of Interatrial Shunting

Overview of HFpEF Disease State and Physiological Rationale for Atrial Shunting

Landmark REDUCE LAP-HF II Trial Demonstrates Clinical Benefit of Corvia Atrial Shunt in Large Segment of Heart Failure Patients

REDUCE LAP-HF II: Atrial Shunt Device Comes Up Short in HFpEF

Putting it into Perspective: Atrial Shunting in the Context of Current Therapies for HFpEF

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content